文献速递间质性肺疾病

表型聚类可预测间质性肺疾病纵向队列的结局

Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort.
PubMed 文献 · Chest · 2017-09-28

该研究在770例纵向间质性肺疾病(ILD)队列中采用聚类分析,基于基线变量识别出4个临床表型,并比较其与现行ATS/ERS ILD分类对结局的预测能力。结果显示,表型聚类在预测每月FVC下降、无进展生存期和无移植生存期方面均显著优于传统诊断分组。

要点

  • 基于基线特征聚类可识别4个ILD临床表型。
  • 聚类4的每月FVC下降为-0.30%,显著大于聚类2的0.01%。
  • 表型聚类独立预测无进展生存期和无移植生存期(P < .001)。

核心结论

  • 在成人慢性ILD中,基于基线特征的聚类分析识别出4个不同临床表型。
  • 表型聚类可能比现行ILD诊断标准更好地预测有临床意义的结局。

研究设计与样本

  • 研究为纵向ILD队列的聚类分析。
  • 基线变量数据完整的受试者共770例。
  • 结局按表型聚类分层,并与按现行ATS/ERS ILD分类标准的亚组分层进行比较。

主要发现

  • 聚类1为年轻白人肥胖女性,基线FVC和DLCO最高。
  • 聚类2为年轻非洲裔美国女性且抗核抗体滴度升高,基线FVC最低。
  • 聚类3为老年白人男性吸烟者合并肺气肿,FVC和DLCO居中。
  • 聚类4为老年白人男性吸烟者伴严重蜂窝影,基线DLCO最低。
  • 按月FVC下降:聚类4为-0.30%,聚类2为0.01%,差异P < .0001。

关键数值与推荐

  • 表型聚类分层独立预测无进展生存期(P < .001)。
  • 表型聚类分层独立预测无移植生存期(P < .001)。

临床怎么用

  • 对ILD患者可基于基线临床特征进行表型聚类评估,以辅助预测FVC下降和生存结局。
  • 表型聚类可能补充现行ATS/ERS诊断分类,用于风险分层和临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The current interstitial lung disease (ILD) classification has overlapping clinical presentations and outcomes. Cluster analysis modeling is a valuable tool in identifying distinct clinical phenotypes in heterogeneous diseases. However, this approach has yet to be implemented in ILD. METHODS: Using cluster analysis, novel ILD phenotypes were identified among subjects from a longitudinal ILD cohort, and outcomes were stratified according to phenotypic clusters compared with subgroups according to current American Thoracic Society/European Respiratory Society ILD classification criteria. RESULTS: Among subjects with complete data for baseline variables (N = 770), four clusters were identified. Cluster 1 (ie, younger white obese female subjects) had the highest baseline FVC and diffusion capacity of the lung for carbon monoxide (Dlco). Cluster 2 (ie, younger African-American female subjects with elevated antinuclear antibody titers) had the lowest baseline FVC. Cluster 3 (ie, elderly white male smokers with coexistent emphysema) had intermediate FVC and Dlco. Cluster 4 (ie, elderly white male smokers with severe honeycombing) had the lowest baseline Dlco. Compared with classification according to ILD subgroup, stratification according to phenotypic clusters was associated with significant differences in monthly FVC decline (Cluster 4, -0.30% vs Cluster 2, 0.01%; P < .0001). Stratification by using clusters also independently predicted progression-free survival (P < .001) and transplant-free survival (P < .001). CONCLUSIONS: Among adults with diverse chronic ILDs, cluster analysis using baseline characteristics identified four distinct clinical phenotypes that might better predict meaningful clinical outcomes than current ILD diagnostic criteria.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Adegunsoye A, Oldham JM, Chung JH, et al. Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest. 2017. PMID: 28964798. doi:10.1016/j.chest.2017.09.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。